[go: up one dir, main page]

ES2043535B1 - PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA. - Google Patents

PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.

Info

Publication number
ES2043535B1
ES2043535B1 ES09200552A ES9200552A ES2043535B1 ES 2043535 B1 ES2043535 B1 ES 2043535B1 ES 09200552 A ES09200552 A ES 09200552A ES 9200552 A ES9200552 A ES 9200552A ES 2043535 B1 ES2043535 B1 ES 2043535B1
Authority
ES
Spain
Prior art keywords
methyl
carbazol
ona
imidazol
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09200552A
Other languages
Spanish (es)
Other versions
ES2043535A1 (en
Inventor
Clotet Juan Huguet
Ges Jose Maria Caldero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Pharma Iberia SL
Original Assignee
Vita Invest SA
Quimica Sintetica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA, Quimica Sintetica SA filed Critical Vita Invest SA
Priority to ES09200552A priority Critical patent/ES2043535B1/en
Priority to SK169-93A priority patent/SK278786B6/en
Priority to GR930100094A priority patent/GR930100094A/en
Priority to CZ93396A priority patent/CZ281753B6/en
Priority to EG14493A priority patent/EG20262A/en
Priority to IS3985A priority patent/IS1783B/en
Priority to PT101216A priority patent/PT101216B/en
Priority to AR93324474A priority patent/AR248019A1/en
Priority to NO930887A priority patent/NO300973B1/en
Priority to KR1019930003609A priority patent/KR100277414B1/en
Priority to PL93298037A priority patent/PL170751B1/en
Priority to HU9300718A priority patent/HU210775B/en
Priority to FI931104A priority patent/FI105098B/en
Priority to RU93004833/04A priority patent/RU2109741C1/en
Priority to AT0048793A priority patent/AT402730B/en
Publication of ES2043535A1 publication Critical patent/ES2043535A1/en
Application granted granted Critical
Publication of ES2043535B1 publication Critical patent/ES2043535B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 1,2,3,9-TETRAHIDRO-9-METIL-3- [(2-METIL-1H-IMIDAZOL-1-IL) METIL] -4H-CARBAZOL-4-ONA DE FORMULA I POR CICLACION DEL COMPUESTO DE FORMULA II BAJO CONDICIONES DE LA ACILACION DE FRIEDELCRAFTS, MEDIANTE ACTIVACION DEL GRUPO CARBOXILO, CON CATALISIS ACIDA, EN UN MEDIO DISOLVENTE ADECUADO Y AISLAR EL PRODUCTO DESEADO POR LOS METODOS CONVENCIONALES. PRESENTA PROPIEDADES COMO ANTIEMETICO EN QUIMIOTERAPIA, ASI COMO EN EL TRATAMIENTO DE LA JAQUECA, ESQUIZOFRENIA, ANSIEDAD, OBESIDAD Y MANIA.PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- [(2-METHYL-1H-IMIDAZOL-1-IL) METHYL] -4H-CARBAZOL-4-ONA OF FORMULA I BY CYCLATION OF THE COMPOUND OF FORMULA II UNDER CONDITIONS OF THE ACILATION OF FRIEDELCRAFTS, THROUGH ACTIVATION OF THE CARBOXYL GROUP, WITH ACID CATALYSIS, IN A SUITABLE SOLVENT ENVIRONMENT AND ISOLATE THE PRODUCT DESIRED BY CONVENTIONAL METHODS. PRESENTS PROPERTIES AS AN ANTIEMETIC IN CHEMOTHERAPY, AS WELL AS IN THE TREATMENT OF MACHINE, SCHIZOPHRENIA, ANXIETY, OBESITY AND MANIA.

ES09200552A 1992-03-13 1992-03-13 PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA. Expired - Fee Related ES2043535B1 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
ES09200552A ES2043535B1 (en) 1992-03-13 1992-03-13 PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.
SK169-93A SK278786B6 (en) 1992-03-13 1993-03-08 METHOD OF PRODUCTION 1,2,3,9-TETRAHYDRO-9-METYL-3 - [(2-MET
GR930100094A GR930100094A (en) 1992-03-13 1993-03-09 A process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1h-imidazol-1-yl)methylÜ-4ii-carbazol-4-one.
EG14493A EG20262A (en) 1992-03-13 1993-03-10 A process for preparing 1,2,3,9- tetrahydro -9- methyl -3-( 2- metyl -1H-imidazol -1- YL) methyl) -4H- carbazol -4- one
CZ93396A CZ281753B6 (en) 1992-03-13 1993-03-10 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-£(2-methyl-1h-imidazol-1-yl)-methyl| -4h-carbazol-4-one
KR1019930003609A KR100277414B1 (en) 1992-03-13 1993-03-11 Method for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl) methyl] -4H-carbazol-4-one
AR93324474A AR248019A1 (en) 1992-03-13 1993-03-11 Procedure for obtaining 1, 2, 3, 9-tetra hydro-9-methyl-3- ((2-methyl-1h-imidazole-1-il)methyl)-4 h-carbazole-4-on a.
NO930887A NO300973B1 (en) 1992-03-13 1993-03-11 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3- [2- (2-methyl-1H-imidazol-1-yl) methyl] -4H-carbazol-4-one
IS3985A IS1783B (en) 1992-03-13 1993-03-11 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3 - [(2-methyl-1H-imidazol-1-yl) methyl] -4H-carbazol-4-one
PT101216A PT101216B (en) 1992-03-13 1993-03-11 PROCESS FOR THE PREPARATION OF 1,2,3,9-TETRAHYDRO-9-METHYL-3 - {(2-METHYL-1H-IMIDAZOL-1-YL) METHYL} -4H-CARBAZOLE-4-ONES
HU9300718A HU210775B (en) 1992-03-13 1993-03-12 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl-4h-carbazol-4-one
FI931104A FI105098B (en) 1992-03-13 1993-03-12 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3 - [(2-methyl-1H-imidazol-1-yl) methyl] -4H-carbazol-4-one
RU93004833/04A RU2109741C1 (en) 1992-03-13 1993-03-12 Method of preparing 1,2,3,9-tetrahydro-9-methyl-3-(2- methyl-1h-imidazol-1-yl)-methyl-4h-carbazol-4-one of formula i
AT0048793A AT402730B (en) 1992-03-13 1993-03-12 Process for the preparation of 1,2,3,9-tetrahydro-9- methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol- 4-one
PL93298037A PL170751B1 (en) 1992-03-13 1993-03-12 4H-carbazolone-4 PL

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09200552A ES2043535B1 (en) 1992-03-13 1992-03-13 PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.

Publications (2)

Publication Number Publication Date
ES2043535A1 ES2043535A1 (en) 1993-12-16
ES2043535B1 true ES2043535B1 (en) 1994-08-01

Family

ID=8276385

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09200552A Expired - Fee Related ES2043535B1 (en) 1992-03-13 1992-03-13 PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.

Country Status (15)

Country Link
KR (1) KR100277414B1 (en)
AR (1) AR248019A1 (en)
AT (1) AT402730B (en)
CZ (1) CZ281753B6 (en)
EG (1) EG20262A (en)
ES (1) ES2043535B1 (en)
FI (1) FI105098B (en)
GR (1) GR930100094A (en)
HU (1) HU210775B (en)
IS (1) IS1783B (en)
NO (1) NO300973B1 (en)
PL (1) PL170751B1 (en)
PT (1) PT101216B (en)
RU (1) RU2109741C1 (en)
SK (1) SK278786B6 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100368895B1 (en) * 2000-03-30 2003-01-24 하나제약 주식회사 A process for preparing 1,2,3,9-tetrahydro-9-methyl-3- [(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one
RU2207340C2 (en) * 2001-08-10 2003-06-27 Ципла Лтд. Method for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazole-4-one or its pharmaceutically acceptable salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT79890B (en) * 1984-01-25 1987-02-03 Glaxo Group Ltd Process for preparing tetrahydro-methylimidazolylcarbazolones
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
SK16993A3 (en) 1993-11-10
HU9300718D0 (en) 1993-05-28
PT101216B (en) 1999-10-29
HUT64537A (en) 1994-01-28
NO300973B1 (en) 1997-08-25
FI931104L (en) 1993-09-14
KR100277414B1 (en) 2001-01-15
KR930019665A (en) 1993-10-18
PL298037A1 (en) 1993-12-27
EG20262A (en) 1998-05-31
PL170751B1 (en) 1997-01-31
AT402730B (en) 1997-08-25
IS1783B (en) 2001-10-22
CZ281753B6 (en) 1997-01-15
CZ39693A3 (en) 1994-01-19
GR930100094A (en) 1993-11-30
ATA48793A (en) 1996-12-15
NO930887D0 (en) 1993-03-11
NO930887L (en) 1993-09-14
FI931104A0 (en) 1993-03-12
PT101216A (en) 1994-03-31
SK278786B6 (en) 1998-02-04
AR248019A1 (en) 1995-05-31
ES2043535A1 (en) 1993-12-16
FI105098B (en) 2000-06-15
HU210775B (en) 1995-07-28
IS3985A (en) 1993-09-14
RU2109741C1 (en) 1998-04-27

Similar Documents

Publication Publication Date Title
ECSP045209A (en) NEW ESTERES OF FLUORENE ACIDS - CARBOXILICS, PROCEDURES FOR THEIR PREPARATION AS WELL AS ITS USE IN QUALITY OF MEDICINES
DE50211793D1 (en)
DE69515893D1 (en) WOOD PRESERVATION FORMULATION CONTAINING A COMPLEX OF COPPER CATION AND ALCOXYLATED DIAMINE
ES2077575T3 (en) PROCEDURE FOR THE PREPARATION OF MODIFIED POLYPHENYLENE-ETER OR RELATED POLYMERS AND THEIR USE IN MODIFIED, HIGH TEMPERATURE RIGID POLYMERS OF VINYL SUBSTITUTED AROMATIC COMPOUNDS.
SV1995000062A (en) DERIVATIVES OF CICLOALCANO-INDOL Y - AZAINDOL REF. Le A 30 699
AR006463A1 (en) COMPOSITION OF MAGNESIUM, TITANIUM, HALOGEN AND ESTER OF CARBOXYLIC ACID; PROCESS FOR ITS PREPARATION, USE OF THE SAME AS A CATALYST, CATALYST COMPONENT OR IN THE PREPARATION OF A CATALYST, PRODUCT OR INTERMEDIATE PRODUCT OF POLYMERIZATION CATALYZED BY THE COMPOSITION OR PREPARED BY
ES2153344T3 (en) PROCEDURE FOR OBTAINING POLYISOCIANATES PRESENTING GROUPS URETDIONA.
AR025163A1 (en) A PROCEDURE FOR PREPARING OLEFINS, A SUPPORTED CATALYSTING SYSTEM, THE USE OF A CATALYSTING COMPOUND OF GROUP 15 CONTAINING HAFNIUM AND THE USE OF A CATALYSTING SYSTEM THAT INCLUDES A CATALYSTING COMPOUND
ES2101994T3 (en) LIQUID ANTIOXIDANTS AS STABILIZERS.
CY1116845T1 (en) S-Fluoromethyl ester of 6.Alpha., 9.Alpha.-Bifluoro-17.Alpha .- [(2-FURANYLCARBONYL) OXY] -11. 1,4, -DIENO-17-CARBONIC ACID AS AN ANTI-INFLAMMATIVE FACTOR
ES8201948A1 (en) A PROCEDURE FOR THE PREPARATION OF NEW TRANSISOMERIC DERIVATIVES OF 4-PHENYL-1,2,3,4- TETRAHYDRO-1-NAFTALENAMINE.
ES2140510T3 (en) SYSTEM TO CONTROL THE COLOR OF ONE OR MULTIPLE POLYMERS IN COMPOSITION USING COLOR MEASUREMENTS DURING THEIR TREATMENT.
ES2083438T3 (en) PROCEDURE FOR THE PREPARATION OF TAXOL USING AN OXAZINONE.
KR940005777A (en) Gelled polymer solution and preparation method thereof
ES2146268T3 (en) PROCEDURE FOR THE MANUFACTURE OF AMIDOETERCARBOXILICO ACID OR OF A SALT THEREOF AND OF A MIXTURE OF AGENTS WITH SURFACE ACTIVITY THAT CONTAIN THEM.
ES2051715T3 (en) THICKENING AGENTS.
ES2130472T3 (en) GUANIDIDES OF ALKENYL CARBOXYLLIC ACIDS SUBSTITUTED WITH PHENYL, CARRIERS OF PERFLUORO-ALKYL GROUPS, PROCEDURE FOR THEIR PREPARATION, USE AS A MEDICINAL PRODUCT OR DIAGNOSTIC AGENT, AS WELL AS A DRUG CONTAINING THEM.
FI911512A0 (en) OEVERBASISKA CALIXARATER, FOERFARANDE FOER DERAS FRAMSTAELLNING, KOMPOSITIONER INNEHAOLLANDE DESAMMA OCH DERAS ANVAENDNING SOM TILLSATSAEMNEN I SMOERJAEMNEN.
ES2043535B1 (en) PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.
JPS6413041A (en) Agent for suppressing growth of polymer in olefin-production apparatus
ES2023455B3 (en) HARDENABLE COMPOSITION ON THE BASIS OF A PRODUCT OF ADDITION-MICHAEL PROCEDURE FOR ITS OBTAINING AS WELL AS ITS APPLICATION.
NO910957L (en) FLUORBENZENESULPHONAMIDS, PROCEDURES FOR PREPARING THEREOF, AND PREPARATIONS CONTAINING SUCH COMPOUNDS.
AR007970A1 (en) SUBSTITUTED PYRROLES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
ES2079464T3 (en) DIPEPTIDIC DERIVATIVES OF MURAMILO.
ES2123827T3 (en) DERIVATIVES OF THE POLYAMIDIC ACID WITH ANTIGASTRINE ACTIVITY, A METHOD FOR ITS PREPARATION AND ITS PHARMACEUTICAL USE.

Legal Events

Date Code Title Description
GC2A Exploitation certificate registered application with search report

Effective date: 19980113

PC2A Transfer of patent
GC2A Exploitation certificate registered application with search report

Effective date: 20030305

PC2A Transfer of patent
PC2A Transfer of patent
PC2A Transfer of patent

Owner name: WARNER CHILCOTT IBERIA, S.L.

Effective date: 20120411

FD2A Announcement of lapse in spain

Effective date: 20141120